Ethical issues of predictive genetic testing for diabetes

Journal of Diabetes Science and Technology

Volumn 3, Issue 4, 2009, Pages 781-788

  Haga, Susanne B ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Ethics; Genetic testing; Risk

Indexed keywords

DIABETES MELLITUS; ETHICS; FINANCIAL MANAGEMENT; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC PRIVACY; GENETIC SCREENING; GENETICS; HUMAN; REVIEW; SOCIAL PSYCHOLOGY;

DIABETES MELLITUS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC TESTING; HUMANS; MARKETING OF HEALTH SERVICES; PREJUDICE;

EID: 77953033662     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300427     Document Type: Conference Paper

References (100)

1. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21(2):296-309.
2. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta: U.S. Department of Health and Human Services; 2008.
3. Centers for Disease Control and Prevention. Incidence of diabetes: crude and age-adjusted incidence of diagnosed diabetes per 1,000 population aged 18-79 years, United States, 1980-2007. http://www.cdc.gov/diabetes/statistics/ incidence/fig2.htm. Accessed October 2008.
4. O'Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end of the beginning? Science. 2005;307(5708):370-3.
5. Freely associating. Nat Genet. 1999;22(1):1-2.
6. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, Barrett JC, Shields B, Morris AP, Ellard S, Groves CJ, Harries LW, Marchini JL, Owen KR, Knight B, Cardon LR, Walker M, Hitman GA, Morris AD, Doney AS, Wellcome Trust Case Control Consortium (WTCCC), McCarthy MI, Hattersley AT. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336-41.
7. Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med. 2006;8(2):102-8.
8. Brownson RC, Remington PL, Davis JR. Chronic disease epidemiology and control. 2nd ed. Washington DC: American Public Health Association; 1998.
9. Harrison TA, Hindorff LA, Kim H, Wines RC, Bowen DJ, McGrath BB, Edwards KL. Family history of diabetes as a potential public health tool. Am J Prev Med. 2003;24(2):152-9.
10. Valdez R, Yoon PW, Liu T, Khoury MJ. Family history and prevalence of diabetes in the US population: 6-year results from the National Health and Nutrition Examination Survey (NHANES, 1999 2004). Diabetes. 2007. [Epub ahead of print.]
11. Centers for Disease Control and Prevention. Crude and age-adjusted incidence of diagnosed diabetes per 1,000 population aged 18-79 years, United States, 1980-2006. http://www.cdc.gov/diabetes/statistics/incidence/fig2. htm.
12. Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, Thornton H, Dundon J, Shaw C, Edwards A. Process and outcome in communication of genetic information within families: a systematic review. Eur J Hum Genet. 2007;15(10):999-1011.
13. Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Noguès C, Bignon YJ, Machelard-Roumagnac M, Maugard-Louboutin C, Serin D, Blanc B, Orsoni P, Sobol H. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet. 1996;33(9):731-6.
14. Green J, Richards M, Murton F, Statham H, Hallowell N. Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns. 1997;6(1):45-60.
15. McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. Am J Med Genet A. 2005;133A(2):165-9.
16. Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, Terdiman J, Chung DC, Syngal S. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol. 2008;6(3):333-8.
17. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A. 2003;116A(1):11-9.
18. Wagner Costalas J, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet C Semin Med Genet. 2003;119C(1):11-8.
19. Ayme S, Macquart-Moulin G, Julian-Reynier C, Chabal F, Giraud F. Diffusion of information about genetic risk within families. Neuromuscul Disord. 1993;3(5-6):571-4.
20. Daly MB, Barsevick A, Miller SM, Buckman R, Costalas J, Montgomery S, Bingler R. Communicating genetic test results to the family: a six-step, skills-building strategy. Fam Community Health. 2001;24(3):13-26.
21. Tercyak KP, Hughes C, Main D, Snyder C, Lynch JF, Lynch HT, Lerman C. Parental communication of BRCA1/2 genetic test results to children. Patient Educ Couns. 2001;42(3):213-24.
22. Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test. 2007;11(3):249-55.
23. Nader PR, Sellers DE, Johnson CC, Perry CL, Stone EJ, Cook KC, Bebchuk J, Luepker RV. The effect of adult participation in a school-based family intervention to improve children's diet and physical activity: the Child and Adolescent Trial for Cardiovascular Health. Prev Med. 1996;25(4):455-64.
24. Cookson S, Heath A, Bertrand L. The HeartSmart Family Fun Pack: an evaluation of family-based intervention for cardiovascular risk reduction in children. Can J Public Health. 2000;91(4):256-9.
25. Golan M, Weizman A. Familial approach to the treatment of childhood obesity: conceptual mode. J Nutr Educ. 2001;33(2):102-7.
26. Kardia SL, Modell SM, Peyser PA. Family-centered approaches to understanding and preventing coronary heart disease. Am J Prev Med. 2003;24(2):143-51.
27. Falk MJ, Dugan RB, O'Riordan MA, Matthews AL, Robin NH. Medical geneticists' duty to warn at-risk relatives for genetic disease. Am J Med Genet A. 2003;120A(3):374-80.
28. Dugan RB, Wiesner GL, Juengst ET, O'Riordan M, Matthews AL, Robin NH. Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience. Am J Med Genet C Semin Med Genet. 2003;119C(1):27-34.
29. Pate v. Threlkel. 661 So.2d 278 (Fla. 1995).
30. Safer v. Estate of Pack. 677 A.2d 1188 (N.J. Super. Ct. App. Div. 1996).
31. Offit K, Groeger E, Turner S, Wadsworth EA, Weiser MA. The "duty to warn" a patient's family members about hereditary disease risks. JAMA. 2004;292(12):1469-73.
32. Chan-Smutko G, Patel D, Shannon KM, Ryan PD. Professional challenges in cancer genetic testing: who is the patient? Oncologist. 2008;13(3):232-8.
33. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. ASHG statement. Professional disclosure of familial genetic information. Am J Hum Genet. 1998;62(2):474-83.
34. Fanos JH. The missing link in linkage analysis: the well sibling revisited. Genet Test. 1999;3(3):273-8.
35. Fanos JH, Johnson JP. Perception of carrier status by cystic fibrosis siblings. Am J Hum Genet. 1995;57(2):431-8.
36. Saukko PM, Ellard S, Richards SH, Shepherd MH, Campbell JL. Patients' understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophilia. BMC Health Serv Res. 2007;7:82.
37. Harrison HF, Harrison BW, Walker AP, Lohman K, Ellis SD, Hall MA, Reiss J, Adams PC, Holup J, Acton RT, Bent T, Rivers C, Fadojutimi-Akinsiku M. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study. Genet Test. 2008;12(4):491-500.
38. Hunt K, Emslie C, Watt G. Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter? Lancet. 2001;357(9263):1168-71.
39. Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr. 1999;25:59-66.
40. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kääriä inen H. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet. 2001;38(11):787-92.
41. Shiloh S. Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns. 2006;15(5):325-37.
42. DeVries H, Mesters I, van de Steeg H, Honing C. The general public's information needs and perceptions regarding hereditary cancer: an application of the Integrated Change Model. Patient Educ Couns. 2005;56(2):154-65.
43. Frosch DL, Mello P, Lerman C. Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1485-9.
44. Marteau T, Senior V, Humphries SE, Bobrow M, Cranston T, Crook MA, Day L, Fernandez M, Horne R, Iversen A, Jackson Z, Lynas J, Middleton-Price H, Savine R, Sikorski J, Watson M, Weinman J, Wierzbicki AS, Wray R, Genetic Risk Assessment for FH Trial Study Group. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet A. 2004;128A(3):285-93.
45. Rose AL, Peters N, Shea JA, Armstrong K. Attitudes and misconceptions about predictive genetic testing for cancer risk. Community Genet. 2005;8(3):145-51.
46. Rose A, Peters N, Shea JA, Armstrong K. The association between knowledge and attitudes about genetic testing for cancer risk in the United States. J Health Commun. 2005;10(4):309-21.
47. Lipkus IM. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making. 2007;27(5):696-713.
48. Catz DS, Green NS, Tobin JN, Lloyd-Puryear MA, Kyler P, Umemoto A, Cernoch J, Brown R, Wolman F. Attitudes about genetics in underserved, culturally diverse populations. Community Genet. 2005;8(3):161-72.
49. Bates BR, Lynch JA, Bevan JL, Condit CM. Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Soc Sci Med. 2005;60(2):331-44.
50. Brunk CG. Public knowledge, public trust: understanding the "knowledge deficit." Community Genet. 2006;9(3):178-83.
51. Cunningham-Burley S. Public knowledge and public trust. Community Genet. 2006;9(3):204-10.
52. Bates BR. Public culture and public understanding of genetics: a focus group study. Public Underst Sci. 2005;14(1):47-65.
53. Scott S, Prior L, Wood F, Gray J. Repositioning the patient: the implications of being "at risk." Soc Sci Med. 2005;60(8):1869-79.
54. Van der Sanden MCA, Meijman FJ. Dialogue guides awareness and understanding of science: an essay on different goals of dialogue leading to different science communication approaches. Public Understanding Sci. 2008;17(1):89-103.
55. Wynne B. Public engagement as a means of restoring public trust in science - hitting the notes, but missing the music? Community Genet. 2006;9(3):211-20.
56. Gottweis H. Gene therapy and the public: a matter of trust. Gene Ther. 2002;9(11):667-9.
57. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
58. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355(3):241-50.
59. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ. 2001;322(7293):1056-9.
60. McBride CM, Bepler G, Lipkus IM, Lyna P, Samsa G, Albright J, Datta S, Rimer BK. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev. 2002;11(6):521-8.
61. Phillips KA, Jenkins MA, Lindeman GJ, McLachlan SA, McKinley JM, Weideman PC, Hopper JL, Friedlander ML, kConFab Investigators. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet. 2006;70(3):198-206.
62. Meiser B, Dunn S, Dixon J, Powell LW. Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: a prospective study. J Genet Couns. 2005;14(6):453-63.
63. Peshkin BN, Schwartz MD, Isaacs C, Hughes C, Main D, Lerman C. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev. 2002;11(10 Pt 1):1115-8.
64. Antill YC, Reynolds J, Young MA, Kirk JA, Tucker KM, Bogtstra TL, Wong SS, Dudding TE, Di Iulio JL, Phillips KA. Screening behavior in women at increased familial risk for breast cancer. Fam Cancer. 2006;5(4):359-68.
65. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord. 2008;22(1):94-7.
66. Sanderson SC, Michie S. Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin Genet. 2007;71(6):501-10.
67. Hicken B, Tucker D. Impact of genetic risk feedback: perceived risk and motivation for health protective behaviours. Psychol Health Med. 2002;7(1):25-36.
68. Moss-Morris R, Petrie KJ. Cognitive distortions of somatic experiences: revision and validation of a measure. J Psychosom Res. 1997;43(3):293-306.
69. Rees G, Fry A, Cull A, Sutton S. Illness perceptions and distress in women at increased risk of breast cancer. Psychol Health. 2004;19(6):749-65.
70. Kaptein AA, van Korlaar IM, Cameron LD, Vossen CY, van der Meer FJ, Rosendaal FR. Using the common-sense model to predict risk perception and disease-related worry in individuals at increased risk for venous thrombosis. Health Psychol. 2007;26(6):807-12.
71. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med. 2006;62(6):1360-8.
72. Cameron LD, Diefenbach MA. Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perceptions. J Health Psychol. 2001;6(1):47-59.
73. Cameron LD, Reeve J. Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychol Health. 2006;21(2):211-30.
74. Smerecnik CM, Mesters I, van Keulen H, Scheffers I, Beeks E, De Leeuw PW, de Vries NK, de Vries H. Should individuals be informed about their salt sensitivity status? First indications of the value of testing for genetic predisposition to low-risk conditions. Genet Test. 2007;11(3):307-14.
75. Johnson JD, Meischke H. A comprehensive model of cancer-related information seeking applied to magazines. Human Commun Res. 1993;19(3):343-67.
76. Perry CF, Bauer KD. Effect of printed tailored messaging on cancer risk behavior. Top Clin Nutr. 2001;16(2):42-52.
77. Ramanadhan S, Viswanath K. Health and the information nonseeker: a profile. Health Commun. 2006;20(2):131-9.
78. Rutten LJ, Squiers L, Hesse B. Cancer-related information seeking: hints from the 2003 Health Information National Trends Survey (HINTS). J Health Commun. 2006;11 Suppl 1:147-56.
79. Baruch S, Hudson K. Civilian and military genetics: nondiscrimination policy in a post-GINA world. Am J Hum Genet. 2008;83(4):435-44.
80. Hudson KL, Rothenberg KH, Andrews LB, Kahn MJ, Collins FS. Genetic discrimination and health insurance: an urgent need for reform. Science. 1995;270(5235):391-3.
81. Offit K, Thom P. Ethical and legal aspects of cancer genetic testing. Semin Oncol. 2007;34(5):435-43.
82. Secretary's Advisory Committee on Genetics, Health, and Society. Public perspectives on genetic discrimination. Bethesda: Department of Health and Human Services; 2004. http://oba.od.nih.gov/oba/sacghs/reports/Public-Perspectives- GenDiscrim.pdf.
83. Penziner E, Williams JK, Erwin C, Bombard Y, Wallis A, Beglinger LJ, Hayden MR, Paulsen JS. Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease. Am J Med Genet B Neuropsychiatr Genet. 2008;147(3):320-5.
84. Public Law 110-233. Genetic Information Nondiscrimination Act of 2008.
85. Slaughter LM. The Genetic Information Nondiscrimination Act: why your personal genetics are still vulnerable to discrimination. Surg Clin North Am. 2008;88(4):723-38, vi.
86. Hudson KL, Holohan MK, Collins FS. Keeping pace with the times - the Genetic Information Nondiscrimination Act of 2008. N Engl J Med. 2008;358(25):2661-3.
87. Zick CD, Mathews CJ, Roberts JS, Cook-Deegan R, Pokorski RJ, Green RC. Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior. Health Aff (Millwood). 2005;24(2):483-90.
88. Centers for Disease Control and Prevention. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing - Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(27):603-6.
89. Mouchawar J, Hensley-Alford S, Laurion S, Ellis J, Kulchak-Rahm A, Finucane ML, Meenan R, Axell L, Pollack R, Ritzwoller D. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005;7(3):191-7.
90. Mouchawar J, Laurion S, Ritzwoller DP, Ellis J, Kulchak-Rahm A, Hensley-Alford S. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Am J Manag Care. 2005;11(10):601-8.
91. Hogarth S, Javitt G, Melzer D. The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet. 2008;9:161-82.
92. Goddard KA, Robitaille J, Dowling NF, Parrado AR, Fishman J, Bradley LA, Moore CA, Khoury MJ. Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics. 2009;12(2):92-104.
93. Gollust SE, Hull SC, Wilfond BS. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA. 2002;288(14):1762-7.
94. Hull SC, Prasad K. Reading between the lines: direct-to-consumer advertising of genetic testing. Hastings Cent Rep. 2001;31(3):33-5.
95. Williams-Jones B. Where there's a web, there's a way: commercial genetic testing and the Internet. Community Genet. 2003;6(1):46-57.
96. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57(5):1233-41.
97. Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet. 1994;31(10):785-97.
98. Nelson RM, Botkjin JR, Kodish ED, Levetown M, Truman JT, Wilfond BS, Harrison CE, Kazura A, Krug E 3rd, Schwartz PA, Donovan GK, Fallat M, Porter IH, Steinberg D, Committee on Bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107(6):1451-5.
99. American Medical Association. Genetic testing in children (Policy E-2.138). http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/ code-medical-ethics/opinion2138.shtml.
100. Borry P, Howard HC, Sénécal K, Avard D. Direct-to-consumer genome scanning services. Also for children? Nat Rev Genet. 2009;10(1):8.